Your browser doesn't support javascript.
loading
cAMP-binding protein Epac induces cardiomyocyte hypertrophy.
Morel, Eric; Marcantoni, Andrea; Gastineau, Monique; Birkedal, Rikke; Rochais, Francesca; Garnier, Anne; Lompré, Anne-Marie; Vandecasteele, Grégoire; Lezoualc'h, Frank.
Affiliation
  • Morel E; Cardiologie Cellulaire et Moléculaire, Inserm U-446, IFR-75, Faculté de Pharmacie, Université Paris XI, 5 Rue JB Clément, 92296 Chatenay Malabry, France.
Circ Res ; 97(12): 1296-304, 2005 Dec 09.
Article in En | MEDLINE | ID: mdl-16269655
ABSTRACT
cAMP is one of the most important second messenger in the heart. The discovery of Epac as a guanine exchange factor (GEF), which is directly activated by cAMP, raises the question of the role of this protein in cardiac cells. Here we show that Epac activation leads to morphological changes and induces expression of cardiac hypertrophic markers. This process is associated with a Ca2+-dependent activation of the small GTPase, Rac. In addition, we found that Epac activates a prohypertrophic signaling pathway, which involves the Ca2+ sensitive phosphatase, calcineurin, and its primary downstream effector, NFAT. Rac is involved in Epac-induced NFAT dependent cardiomyocyte hypertrophy. Blockade of either calcineurin or Rac activity blunts the hypertrophic response elicited by Epac indicating these signaling molecules coordinately regulate cardiac gene expression and cellular growth. Our results thus open new insights into the signaling pathways by which cAMP may mediate its biological effects and identify Epac as a new positive regulator of cardiac growth.
Subject(s)
Search on Google
Database: MEDLINE Main subject: Cardiomegaly / Guanine Nucleotide Exchange Factors Type of study: Prognostic_studies Limits: Animals Language: En Year: 2005 Type: Article
Search on Google
Database: MEDLINE Main subject: Cardiomegaly / Guanine Nucleotide Exchange Factors Type of study: Prognostic_studies Limits: Animals Language: En Year: 2005 Type: Article